Accelerating mRNA Therapy Production With Digital Innovation

By Madalina Miron, Emerson

Messenger RNA (mRNA) therapies are redefining the future of medicine, offering promise for personalized vaccines and rare disease treatments. But scaling production remains a major hurdle. From fragile molecules to complex bioprocesses, manufacturers face challenges that demand precision and agility. Digital technologies—like digital twins, process automation, and real-time analytics—are emerging as essential tools to meet these demands. These solutions not only streamline operations but also enhance reproducibility, compliance, and speed to market. With the right digital strategy, life sciences companies can transform mRNA production from a bottleneck into a competitive advantage.

Explore how integrated digital platforms can support every stage of therapy development, from R&D to commercialization.